Promising new weight-loss medications can be costly — but so is the impact of obesity on worker health and productivity. The question for employers is whether it makes sense to include such drugs as Ozempic, Wegovy and the newly launched Mounjaro in their health plans.

One thing everyone agrees on is the prevalence of obesity and its impact on health. It is linked to heightened risks for more than 50 health problems, including diabetes, heart disease, stroke and certain types of cancer, according to a new report from Goodroot. Adult obesity rates have risen from 30.5% of the U.S. population in 2000 to 42% in 2020. The escalating prevalence of obesity and pre-obesity underlines the urgent need for comprehensive strategies to address this national health crisis.

Weight-loss drugs, like most pharmaceuticals, come with tradeoffs. On the positive side, clinical trials for Wegovy, a weekly injectable, indicated that patients lost an average of 15% of their body weight over a 68-week period. Studies involving diabetic patients using Rybelsus, the daily oral version of semaglutide, recorded a more modest weight loss of 5% to 7% over one year. However, in the ongoing oral semaglutide trial for weight loss, a considerably higher dosage is being administered. It is anticipated that with this higher dosage, results will align more closely with those reported for injectable versions.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?


© 2023 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

BenefitsPRO Broker Expo 2024Event

The premier educational and networking event for employee benefits brokers and agents.

Get More Information


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.